Discgenics is a biotechnology company focused on developing regenerative cell-based therapies to treat degenerative diseases of the spine. Their innovative approach harnesses the body’s natural biology to repair and regenerate damaged spinal discs, offering hope to patients suffering from chronic back pain.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#193 in Salt Lake City, UT

#496 in Utah

#39,950 in US

Salt Lake City, UT, United States of America

Discgenics

Forward Citations = 12

8 inventors:

Christopher Duntsch (6 out of 6 patents)

Valery Kukekov (4 out of 4 patents)

Umar Akbar (3 out of 3 patents)

4. Valery Kukekeov (2 out of 2 patents)

5. Tatyana Igantova (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Discgenics. Retrieved from https://idiyas.com/company/discgenics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]